Influenza News and Research

Latest Influenza News and Research

New highly sensitive test for dengue virus developed using DNA star

Researchers have developed a new method for detecting and destroying the dengue virus that could be adapted for other viruses.

25 Nov 2019

Efforts to move the needle on flu shot rates get stuck

It's free and available everywhere. Yet most Americans skip the annual flu shot - with the number of dispensed vaccines barely changed in the past decade, despite government removal of cost and access obstacles.

21 Nov 2019

Study examines prevalence of Miller-Fisher syndrome after vaccination in the U.S.

A recent study published in Muscle & Nerve created by the Centers for Disease Control and Prevention/Food and Drug Administration examined the prevalence of Miller-Fisher syndrome (MFS) occurring after vaccination in the United States.

21 Nov 2019

Influenza vaccine found to be safe for people with autoimmune neuromuscular disorders

A recent study published in Muscle & Nerve appears to show that the influenza vaccination is safe to use for those with autoimmune neuromuscular disorders.

20 Nov 2019

Ketogenic diet wards off flu, study finds

The ketogenic diet has gained immense popularity over the past years because it helps lose weight speedily, with a wide range of health benefits. Similar to the Atkins diet, the ketogenic diet may not only help people shed off extra pounds but also boosting the immune system and warding off flu.

19 Nov 2019

Mysterious feather duvet lung disease nearly kills a man

A soft pillow and a warm duvet are all you need to have a soothing and relaxing sleep, especially during the frigid season. However, a man from the United Kingdom nearly died because of a mysterious illness related to a duvet. It was later found out by doctors that the culprit for his lung disease is his newly-bought feather duvet.

19 Nov 2019

Legislation and rising incidence of vaccine preventable diseases – the connection explored

There have been repeated reports of outbreaks of “vaccine-preventable disease” or VPDs across United States over the past few years. A new research letter was published this week in the JAMA Pediatrics. It was titled, “Association of Vaccine-Preventable Disease Incidence With Proposed State Vaccine Exemption Legislation.”

18 Nov 2019

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

A team of researchers in the Department of Microbiology, Immunology and Pathology at Colorado State University aim to advance what is known about the complex immune response necessary to prevent tuberculosis disease.

15 Nov 2019

Four important tips to stay safe and healthy during winter

Colder temperatures, inclement weather, changes in the amount of daylight, and the spread of cold and flu viruses can all have a significant impact on your winter well-being, making it more challenging for you to stay safe and healthy.

15 Nov 2019

Researchers take major step towards developing a viable vaccine for malaria

Researchers have narrowed down the malaria proteins and disease-fighting antibodies that could be used to develop a vaccine against the most severe forms of malaria.

13 Nov 2019

Scientists move closer towards developing an effective malaria vaccine

Scientists have taken another big step forward towards developing a vaccine that’s effective against the most severe forms of malaria.

13 Nov 2019

FIRS calls for an end to preventable deaths from pneumonia

In support of World Pneumonia Day, Nov. 12, the Forum of International Respiratory Societies, of which the American Thoracic Society is a member, calls for an end to preventable pneumonia deaths, ensuring equitable access to interventions for prevention and control of pneumonia.

12 Nov 2019

New vaccine strategy shows promise against HIV

A collaborative team of scientists has made a successful proof-of-principle demonstration of an advanced HIV vaccine strategy--an approach that may also work in protecting people from an array of other deadly infectious diseases.

7 Nov 2019

San Diego-based Predictive Science releases first forecast for influenza season

San Diego-based Predictive Science, Inc. this week released their first forecast for the 2019-2020 influenza season, which typically runs from November through March.

4 Nov 2019

Chest infections cause 1 in 7 child deaths

The number of deaths in children due to lower respiratory infections (LRIs) such as pneumonia and influenza has come down considerably. Yet, they still account for the highest number of deaths in children under 5 years of age, at one in seven of all deaths in this age group, according to a detailed study published in the journal The Lancet Infectious Diseases.

31 Oct 2019

Study shows how measles virus causes immune amnesia

Over the last decade, evidence has mounted that the measles vaccine protects in not one but two ways: Not only does it prevent the well-known acute illness with spots and fever that frequently sends children to the hospital, but it also appears to protect from other infections over the long term.

31 Oct 2019

OHSU receives $2.1 million to develop new vaccine additives for tropical viruses

Sometimes vaccines need a little help to protect people against infectious diseases.

31 Oct 2019

Facebook takes social media into preventive health – but is it private?

Facebook’s (FB) new Preventive Health Tool has been set up to connect its users to resources and reminders for health assessments in three major areas – heart disease and stroke, cancer, and seasonal influenza – thus making it easier for FB fans to remember to look after their health as well.

29 Oct 2019

Sense Biodetection raises £12.3m to develop instrument-free, point-of-care molecular diagnostic tests

Sense Biodetection Limited has today announced that it has raised £12.3m to develop its portfolio of instrument-free, point-of-care molecular diagnostic tests, a pioneering new class of diagnostic product.

29 Oct 2019

Novel antibodies could provide a universal flu vaccine

Now, a new study published in the journal Science on October 25, 2019, reports on a set of three novel antibodies that bind to another type of viral cell surface antigen called neuraminidase (NA) that is necessary for viral replication.

28 Oct 2019

Influenza News and Research

Latest Influenza News and Research

New highly sensitive test for dengue virus developed using DNA star

Efforts to move the needle on flu shot rates get stuck

Study examines prevalence of Miller-Fisher syndrome after vaccination in the U.S.

Influenza vaccine found to be safe for people with autoimmune neuromuscular disorders

Ketogenic diet wards off flu, study finds

Mysterious feather duvet lung disease nearly kills a man

Legislation and rising incidence of vaccine preventable diseases – the connection explored

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

Four important tips to stay safe and healthy during winter

Researchers take major step towards developing a viable vaccine for malaria

Scientists move closer towards developing an effective malaria vaccine

FIRS calls for an end to preventable deaths from pneumonia

New vaccine strategy shows promise against HIV

San Diego-based Predictive Science releases first forecast for influenza season

Chest infections cause 1 in 7 child deaths

Study shows how measles virus causes immune amnesia

OHSU receives $2.1 million to develop new vaccine additives for tropical viruses

Facebook takes social media into preventive health – but is it private?

Sense Biodetection raises £12.3m to develop instrument-free, point-of-care molecular diagnostic tests

Novel antibodies could provide a universal flu vaccine

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Influenza News and Research

Latest Influenza News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in